Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial

INTRODUCTION: Research in recent years has shown the potential benefits of fecal microbiota transplantation (FMT) for irritable bowel syndrome (IBS). Acute infectious gastroenteritis is a well-established risk factor for developing such forms of IBS as post-infectious IBS (PI-IBS). However, the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tkach, Sergii, Dorofeyev, Andrii, Kuzenko, Iurii, Sulaieva, Oksana, Falalyeyeva, Tetyana, Kobyliak, Nazarii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631772/
https://www.ncbi.nlm.nih.gov/pubmed/36341232
http://dx.doi.org/10.3389/fmed.2022.994911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631772/
https://www.ncbi.nlm.nih.gov/pubmed/36341232
http://dx.doi.org/10.3389/fmed.2022.994911

Ejemplares similares